178 related articles for article (PubMed ID: 6801127)
1. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.
Krettli AU; Brener Z
J Immunol; 1982 May; 128(5):2009-12. PubMed ID: 6801127
[TBL] [Abstract][Full Text] [Related]
2. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies.
Almeida IC; Milani SR; Gorin PA; Travassos LR
J Immunol; 1991 Apr; 146(7):2394-400. PubMed ID: 1706399
[TBL] [Abstract][Full Text] [Related]
3. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
Wallace A; Sanchez G; Venegas J; Solari A
Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
[TBL] [Abstract][Full Text] [Related]
4. Antibody-independent, natural resistance of birds to Trypanosoma cruzi infection.
Kierszenbaum F; Gottlieb CA; Budzko DB
J Parasitol; 1981 Oct; 67(5):656-60. PubMed ID: 6795329
[TBL] [Abstract][Full Text] [Related]
5. Human and mouse sera recognize the same polypeptide associated with immunological resistance to Trypanosoma cruzi infection.
Martins MS; Hudson L; Krettli AU; Cançado JR; Brener Z
Clin Exp Immunol; 1985 Aug; 61(2):343-50. PubMed ID: 2412745
[TBL] [Abstract][Full Text] [Related]
6. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.
Krettli AU; Weisz-Carrington P; Nussenzweig RS
Clin Exp Immunol; 1979 Sep; 37(3):416-23. PubMed ID: 116784
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous lytic activity against allogeneic tumor cells and depression of specific cytotoxic responses in mice infected with Trypanosoma cruzi.
Hatcher FM; Kuhn RE
J Immunol; 1981 Jun; 126(6):2436-42. PubMed ID: 6785354
[TBL] [Abstract][Full Text] [Related]
8. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
[TBL] [Abstract][Full Text] [Related]
9. Cytophilic antibody in experimental Chagas' disease.
Kuhn RE; Cassida GW
J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response.
Miller MJ; Wrightsman RA; Manning JE
Exp Parasitol; 1996 Nov; 84(2):156-67. PubMed ID: 8932765
[TBL] [Abstract][Full Text] [Related]
11. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells.
Nickell SP; Stryker GA; Arevalo C
J Immunol; 1993 Feb; 150(4):1446-57. PubMed ID: 8432987
[TBL] [Abstract][Full Text] [Related]
12. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
Umezawa ES; Shikanai-Yasuda MA; Stolf AM
J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
[TBL] [Abstract][Full Text] [Related]
13. Parasite specific antibodies in three strains of mice after infection with Trypanosoma cruzi.
Zweerink HJ; Anderson OF; Greenblatt HC; Murray PK
J Parasitol; 1985 Feb; 71(1):43-9. PubMed ID: 3920376
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi: the fate of bloodstream trypomastigote, amastigote, metacyclic trypomastigote and epimastigote forms in the peritoneal macrophages of immune and non-immune mice in vivo.
Burger E; Lay WH; Hypolito LV; Fernandes JF
Acta Trop; 1982 Jun; 39(2):111-22. PubMed ID: 6126093
[TBL] [Abstract][Full Text] [Related]
15. Measurement of cytolytic antibody in experimental Chagas' disease using a terminal radiolabelling procedure.
Powell MR; Kuhn RE
J Parasitol; 1980 Jun; 66(3):399-406. PubMed ID: 6771377
[TBL] [Abstract][Full Text] [Related]
16. Immunological studies in Rockland mice infected with T. cruzi. Development of antinuclear antibodies.
Szarfman A; Cossio PM; Laguens RP; Segal A; De La Vega MT; Arana RM; Schmuñis GA
Biomedicine; 1975 Nov; 22(6):489-95. PubMed ID: 131587
[TBL] [Abstract][Full Text] [Related]
17. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
Wizel B; Nunes M; Tarleton RL
J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
[TBL] [Abstract][Full Text] [Related]
18. Immunization against Trypanosoma cruzi using killed antigens and with saponin as adjuvant.
Neal RA; Johnson P
Acta Trop; 1977 Mar; 34(1):87-96. PubMed ID: 16471
[TBL] [Abstract][Full Text] [Related]
19. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of trypomastigotes' infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi.
Imaz MS; Esteva M; Velázquez E; Ruiz AM; Segura EL; Marcipar AJ
Rev Latinoam Microbiol; 1997; 39(1-2):33-46. PubMed ID: 10932713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
